Identity area
Reference code
Title
Date(s)
- 1998-1999 (Creation)
Level of description
Extent and medium
Extent: 1 folder
Context area
Repository
Archival history
Content and structure area
Scope and content
Articles by and about the American biotechnology company Monsanto including interview/essay by Hugh Grant (CEO), emails from Tony Combes of MONSANTO on company policies, combating bad press, GM issues and copies of articles on Genetic engineering; article 'CGIAR Centers' Position on Genetic Resources, Intellectual Property Rights and Biotechnology'; email correspondence with Greg A Penner
Accruals
System of arrangement
Conditions of access and use area
Conditions governing access
Conditions governing reproduction
Language of material
Script of material
Language and script notes
Physical characteristics and technical requirements
Finding aids
Allied materials area
Existence and location of originals
Existence and location of copies
Related units of description
Notes area
Note
Admin History: Monsanto Company was an agrochemical and agricultural biotechnology corporation. It was headquartered in Creve Coeur, Greater St. Louis, Missouri. Monsanto was one of the first companies to apply the biotechnology industry business model to agriculture, using techniques developed by biotech drug companies. In this business model, companies recoup R&D expenses by exploiting biological patents. Monsanto's roles in agricultural changes, biotechnology products and lobbying of government agencies and roots as a chemical company resulted in controversies. The company once manufactured controversial products such as the insecticide DDT, PCBs, Agent Orange and recombinant bovine growth hormone. Its seed patenting model was criticized as biopiracy and a threat to biodiversity. In September 2016, Bayer announced its intent to acquire Monsanto for US$66 billion. After gaining US and EU regulatory approval, the sale was completed on June 7, 2018.